Olanzapine Glenmark

Medicinal product

(Invented) name

Olanzapine Glenmark

Active substance (s)

Olanzapinas

Strength

10 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N05AH03, Olanzapine

Marketing authorisation holder

Glenmark Arzneimittel GmbH, Vokietija

Date of authorisation

2009-12-03

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Tablet	1 vnt.
Olanzapinas	10 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
38823	52505	1052505	lizdinė plokštelė	N28		Receptinis	EU/1/09/587/010	Netiekiama	-	-	No	-	-
38824	52506	1052506	lizdinė plokštelė	N56		Receptinis	EU/1/09/587/011	Netiekiama	-	-	No	-	-
38825	52507	1052507	lizdinė plokštelė	N70		Receptinis	EU/1/09/587/012	Netiekiama	-	-	No	-	-
100860	86971	1086971	lizdinė plokštelė	N98		Receptinis	EU/1/09/587/023	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2009-12-03	Registruotas